Genetic variants in CYP11B1 influence the susceptibility to coronary heart disease

被引:5
|
作者
Huang, Xiaoli [1 ]
Cheng, Yimin [2 ]
Wang, Na [1 ]
机构
[1] Xian Hosp Tradit Chinese Med, Dept Cardiovascol, 69 Fengcheng Eighth Rd, Xian 710021, Peoples R China
[2] Hosp Xian Shiyou Univ, Dept Obstet & Gynecol, Xian 710065, Peoples R China
关键词
Coronary heart disease; Polymorphisms; Susceptibility; Gene; POLYMORPHISMS; RISK;
D O I
10.1186/s12920-022-01307-8
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Genetic factors are important risk factors to develop coronary heart disease (CHD). In this study, we mainly explored whether CYP11B1 mutations influence CHD risk among Chinese Han population. Methods Six variants were genotyped using Agena MassARRAY system from 509 CHD patients and 509 healthy controls. The correlations between CYP11B1 mutations and CHD risk were assessed using odds ratio (OR) and 95% confidence interval (95% CI) by logistic regression. The haplotype analysis and were ultifactor dimensionality reduction (MDR) were conducted. Results In the overall analysis, CYP11B1 polymorphisms were not correlated with CHD susceptibility. In the stratified analysis, we found that rs5283, rs6410, and rs4534 are significantly associated with susceptibility to CHD dependent on age and gender (p < 0.05). Moreover, we also observed that rs5283 and rs4534 could affect diabetes/hypertension risk among CHD patients (p < 0.05). In addition, the C(rs4736312)A(rs5017238)C(rs5301)G(rs5283)T(rs6410)C(rs4534) haplotype of CYP11B1 reduce the susceptibility to CHD (p < 0.05). Conclusions We found that rs4534, rs6410 and rs5283 in CYP11B1 gene influence the susceptibility to CHD, which depend on age and gender.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] A novel chimeric CYP11B2/CYP11B1 combined with a new p.L340P CYP11B1 mutation in a patient with 11OHD: case report
    Lian Duan
    Rufei Shen
    Lingyu Song
    Yong Liao
    Hongting Zheng
    BMC Endocrine Disorders, 18
  • [22] Structure/function relationship of CYP11B1 associated with Dahl's salt-resistant rats -: Expression of rat CYP11B1 and CYP11B2 in Escherichia coli
    Nonaka, Y
    Fujii, T
    Kagawa, N
    Waterman, MR
    Takemori, H
    Okamoto, M
    EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 258 (02): : 869 - 878
  • [23] Contribution of lncRNA CASC8, CASC11, and PVT1 Genetic Variants to the Susceptibility of Coronary Heart Disease
    Lu, Yan
    Yuan, Wei
    Wang, Lan
    Ning, Mingan
    Han, Yuan
    Gu, Wenjuan
    Zhao, Tingting
    Shang, Fenqing
    Guo, Xuan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (06) : 756 - 766
  • [24] Congenital adrenal hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants
    I. Fylaktou
    P. Smyrnaki
    A. Sertedaki
    M. Dracopoulou
    Ch. Kanaka-Gantenbein
    Hormones, 2022, 21 : 155 - 161
  • [25] Congenital adrenal hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants
    Fylaktou, I
    Smyrnaki, P.
    Sertedaki, A.
    Dracopoulou, M.
    Kanaka-Gantenbein, Ch
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2022, 21 (01): : 155 - 161
  • [26] Pharmacogenetic study of ACE, AGT, CYP11B1, CYP11B2 and eNOS gene variants in hypertensive patients from Faisalabad, Pakistan
    Hussain, Misbah
    Bilal, Ahmed
    Awan, Fazli Rabbi
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2020, 70 (04) : 624 - 629
  • [27] Case Report: A combination of chimeric CYP11B2/CYP11B1 and a novel p.Val68Gly CYP11B1 variant causing 11β-Hydroxylase deficiency in a Chinese patient
    Li, Jialin
    Zhang, Fenglan
    Xu, Miao
    Qiu, Hao
    Zhou, Cheng
    Li, Li
    Qin, Lan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [28] Detection and activity of 11 beta hydroxylase (CYP11B1) in the bovine ovary
    Amweg, A. N.
    Rodriguez, F. M.
    Huber, E.
    Marelli, B. E.
    Gareis, N. C.
    Belotti, E. M.
    Rey, F.
    Salvetti, N. R.
    Ortega, H. H.
    REPRODUCTION, 2017, 153 (04) : 433 - 441
  • [29] A chimeric CYP11B1/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism
    Ise, T
    Shimoda, A
    Takakuwa, H
    Kato, T
    Izumiya, Y
    Shimizu, K
    Suzuki, T
    Sasano, H
    Yokoyama, H
    Kobayashi, K
    CLINICAL ENDOCRINOLOGY, 2001, 55 (01) : 131 - 134
  • [30] A novel mutation in the CYP11B1 gene in a patient with 11β-hydroxylase deficiency
    Motaghedi, R
    Slowinska, B
    Cerami, B
    Cabrera, M
    New, MI
    Wilson, RC
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 79A - 79A